Analytical Bioventures S.C.A., a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin, acquired Eurofins shares in three transactions on Euronext Paris under European market abuse rules.
verifying reliability
No specialized terms available for this topic.